|
Khasabov, Sergey G |
University Of Minnesota |
Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling |
Supportive Care and Symptom Management, Pain |
PA-20-185: NIH Research Project Grant |
|
Kahalley, Lisa Schum |
Baylor College Of Medicine |
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy. |
Supportive Care and Symptom Management, Multiple Symptoms, Pediatrics/Adolescents/Young Adult, Cognitive Dysfunction |
PA-19-056: Research Project Grant |
|
Kahalley, Lisa Schum |
Baylor College Of Medicine |
White Matter Toxicity and Neurocognitive Outcomes in Pediatric Brain Tumor Patients Treated with Proton Beam Radiation Therapy |
Supportive Care and Symptom Management, Pediatrics/Adolescents/Young Adult, Cognitive Dysfunction |
PA-16-160: NIH Research Project Grant |
|
Jim, Heather S.L. |
H. Lee Moffitt Cancer Ctr & Res Inst |
Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue |
Supportive Care and Symptom Management, Fatigue |
PA-16-160: NIH Research Project Grant |
|
Jatoi, Aminah |
Mayo Clinic Rochester |
Palliating EGFR Inhibitor Rash in African American and Other Cancer Patients |
Supportive Care and Symptom Management, Skin Toxicities |
PA-16-160: NIH Research Project Grant |
|
Jaslowski, Anthony J |
St. Vincent Hospital |
Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium |
NCI Community Oncology Research Program, NCORP Community Sites |
RFA-CA-18-016: NCI Community Oncology Research Program (NCORP) Community Sites |
|
Irvin, William J |
Southeast Clinical Oncol Res Consortium |
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required) |
NCI Community Oncology Research Program, NCORP Community Sites |
RFA-CA-18-016: NCI Community Oncology Research Program (NCORP) Community Sites |
|
Infante, Rodney E |
Ut Southwestern Medical Center |
Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia |
Supportive Care and Symptom Management, Anorexia |
PA-20-185: NIH Research Project Grant |
|
Im, Eun-Ok |
Emory University |
Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors |
Supportive Care and Symptom Management, Pain |
RFA-NS-22-037: HEAL Initiative: Advancing Health Equity in Pain and Comorbidities |
|
Ibrahim, Mohab M |
University Of Arizona |
Repurposing Sulfasalazine in a Two-Arm Phase Two Double-Blind Randomized Clinical Trial for the Adjunct Management of Breast Cancer-Induced Bone Pain |
Supportive Care and Symptom Management, Pain |
PAR-19-356: NCI Clinical and Translational Exploratory/Developmental Studies |
|
Hundley, William Gregory |
Wake Forest University Health Sciences |
Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment |
Supportive Care and Symptom Management, Quality of Life |
PAR-18-307: Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional) |
|
Hui, David |
University Of Tx Md Anderson Can Ctr |
Strategies for Persistent Agitated Delirium in Palliative Care |
Supportive Care and Symptom Management, Cognitive Dysfunction |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Hui, David |
University Of Tx Md Anderson Can Ctr |
Efficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients |
Supportive Care and Symptom Management, Other Supportive Care Issues |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Huberty, Jennifer Lynne |
University Of Texas Hlth Science Center |
Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients |
Supportive Care and Symptom Management, Sleep Disorders |
PA-21-268: Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) |
|
Hu, Shuiying |
Ohio State University |
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib |
Provocative QuestionsSupportive Care and Symptom Management, Neuropathy |
RFA-CA-18-019: Research Answers to National Cancer Institute's (NCI) Provocative Questions |
